Abstract: Pollution from industrial plants which produce NO.sub.x and waste water is reduced by utilizing waste water to prepare aqueous NO.sub.x -reducing solutions. Total water hardness in the waste water is preferably maintained below 2500 ppm, silicate below 200 ppm and the calcium to magnesium ratio above 2:1. The aqueous NO.sub.x -reducing solution will preferably contain hardness suppressing compostions in effective amounts.

Abstract: This invention provides a new use of acids, esters, and salts of arylmethylphosphonates of Formula I, ##STR1## or a phosphonic acid of Formula II ##STR2## and derivatives as anti-inflammatory and anti-arthritic agents. Representative compounds include 4-dodecyloxybenzylphosphonic acid dimethyl ester, (2-naphthalenylmethyl)phosphonic acid dimethyl ester, and ([1,1'-biphenyl]-2-ylmethyl)phosphonic acid dimethyl ester.

Abstract: A business form having an integrated label in its top ply or other sheets advantageously includes a release sheet which is only partially covered with a release coating in order to provide a controlled release. The controlled release is provided by skiving lines which preferably remove a portion of the release coating within a border on the release sheet. The adhesive layer is thereby directly connected to both the label and the release sheet. The release coating is penetrated intermittently by the skiving lines to remove a portion of the release coating. Alternatively, a pattern of release coating of silicone or the like may be printed in a pattern so that the release coating is only intermittently provided in covering relationship over the release sheet. The provision of intermittent direct contact between the adhesive and the release sheet provides improved adhesion of the label to the liner without detracting from the functionality of the form or the label.

Abstract: This invention provides 7-deoxy-.DELTA..sup.6,7 -taxol and 7-deoxy-.DELTA..sup.6,7 -taxol analogs of Formula I: ##STR1## The compounds of Formula I are useful for the same cancers for which taxol has been shown active, including human ovarian cancer, breast cancer, and malignant melanoma as well as lung cancer, gastric cancer, colon cancer, head and neck cancer, and leukemia.

Abstract: This invention provides a new use of acids, esters, and salts of arylmethylphosphonates of Formula I, ##STR1## or phosphonic acid derivatives of Formula II ##STR2## as anti-inflammatory and anti-arthritic agents. Representative compounds include 4-dodecyloxybenzylphosphonic acid dimethyl ester, (2-naphthalenylmethyl)phosphonic acid dimethyl ester, and ([1,1 '-biphenyl]-2-ylmethyl)phosphonic acid dimethyl ester. The invention also provides novel acids, esters, and salts of arylmethylphosphonic acid, phosphonic acid and derivatives.

Abstract: An apparatus and method for the continuous manufacture of printed, laminated stock is provided. The apparatus is designed to use plain, uncoated webs and at separate stations along a continuous path apply a release coating, apply an adhesive, join the webs together and imprint the combined webs to yield a final, laminated and imprinted stock. By die cutting and stripping the stock at further stations, discrete elements such as labels may be produced and carried by one of the webs. The apparatus preferably includes stations for curing and remoisturizing the release coated web, whereby a known moisture content is provided for the release coating prior to the application of adhesive and joining the webs into laminated stock. The process includes providing respective webs, applying a release coating to one web, joining the two webs together, imprinting at least one of the webs and routing the combined webs to a delivery station whereby the entire process is continuous and uninterrupted.

Abstract: A business form having a base sheet and a web adhered thereto forming a discrete pocket is provided. The web is applied and adhered to the base sheet whereby the surrounding margin of the web is recessed from the circumscribing edge of the base sheet. The continuous form can be fan-folded without binding or interference as the fold lines of the base sheet are free from interference by the web, The base sheet may be coated with carbonless transfer media as may be an insert ply positioned between the web and the base sheet to permit inscriptions on the base sheet to be transferred to a ply which may be subsequently removed.

Abstract: Provided are cyclic hydrocarbons of Formula I ##STR1## with an aminoalkyl sidechain that are useful for treating phospholipase A2 mediated conditions, diabetes, and obesity.

Abstract: Novel acids, esters, and salts of phenyl, naphthyl, quinoxalinyl, and biphenyl bisphosphonic acids and 1,2-oxaphosphepins are described. These compounds are useful as antiinflammatory and anti-arthritic agents. Also described are known compounds of the phenyl, naphthyl, quinoxalinyl, and biphenyl bisphosphonate classes which are also useful as antiinflammatory and anti-arthritic agents. Representative compounds include [1,2-phenyldiyl]bis(methylene)bisphosphonic acid tetramethyl ester, [2,3-quinoxalindiyl]bis(methylene)bisphosphonic acid tetramethyl ester, [[3-(propyl)-4-(methoxy)-1,8-naphthalenediyl]bis(methylene)]bisphosphonic acid tetramethyl ester, [2,6-naphthalenediylbis(methylene)bisphosphonic acid tetraethyl ester, and [2,2'-biphenylenebis(methyl)]bisphosphonic acid tetramethyl ester. Representative oxaphosphepins include the preferred 3,4-dihydro-3-methoxy-7-(phenylmethoxy)-1H-naphth[1,8de][1,2]oxaphosphepin -3-oxide.

Abstract: Provided are novel dialkyl (dialkoxyphosphinyl)methyl phosphates of formula ##STR1## which am useful as anti-inflammatory and anti-arthritic agents. The compounds are synthesized from the reaction of tetraethyl oxiranylidenebisphosphonate and unsubstituted or alkyl-amines. Representative compounds include 2-(benzylamino)-1-(diethoxyphosphinyl)ethyl phosphonic acid diethyl ester, 1-(diethoxyphosphinyl)-2-[2'-(1', 2', 3', 4'-tetrahydro)napthylamino]ethyl phosphonic acid diethyl ester, 2-(3-fluorobenzylamino)-1-(diethoxyphosphinyl)ethyl phosphonic acid diethyl ester, and 5,5 -dimethyl-2-[2-(3-fluorobenzyl)amino-1-[(5,5-dimethyl-1,3,2-dioxaphosphori nan-2-yl)oxy]ethyl]-1,3,2-dioxaphosphorinane P,2-dioxide.

Abstract: Provided are cyclic hydrocarbons of Formula I ##STR1## with an aminoalkyl sidechain that are useful for treating phospholipase A2 mediated conditions, diabetes, and obesity.

Abstract: Novel acids, esters, and salts of phenyl, naphthyl, quinoxalinyl, and biphenyl bisphosphonic acids and 1,2-oxaphosphepins are described. These compounds are useful as antiinflammatory and anti-arthritic agents. Also described are known compounds of the phenyl, naphthyl, quinoxalinyl, and biphenyl bisphosphonate classes which are also useful as antiinflammatory and anti-arthritic agents. Representative compounds include [1,2-phenyldiyl]bis (methylene)bisphosphonic acid tetramethyl ester, [2,3-quinoxalindiyl]bis(methylene)bisphosphonic acid tetramethyl ester, [[3-(propyl)-4-(methoxy)-1,8-naphthalenediyl]bis(methylene)]bisphosphonic acid tetramethyl ester, [2,6-naphthalenediylbis(methylene) bisphosphonic acid tetraethyl ester, and [2,2'-biphenylenebis(methyl)]bisphosphonic acid tetramethyl ester. Representative oxaphosphepins include the preferred 3,4-dihydro-3-methoxy -7-(phenylmethoxy)-1H-naphth[1,8de][1,2]oxaphosphepin-3-oxide.

Abstract: A process for the reduction of nitrogen oxides in the effluent of a gas turbine is presented. This process comprises forming an emulsion which comprises water and fuel oil and combusting the emulsion in the combustion can of a gas turbine to form an effluent; and contacting the effluent with a catalyst effective for the reduction of nitrogen oxides therein.

Abstract: Provided are cyclic hydrocarbons of Formula I ##STR1## with an aminoalkyl sidechain that are useful for treating phospholipase A2 mediated conditions, diabetes, and obesity.

Abstract: Provided are cyclic hydrocarbons of Formula I ##STR1## with an aminoalkyl sidechain.

Abstract: Provided are cyclic hydrocarbons of Formula I ##STR1## with an aminoalkyl sidechain that are useful for treating phospholipase A2 mediated conditions, diabetes, and obesity.

Abstract: A roll-formed door beam is provided for a vehicle which has an elongated shaped including a hat shaped portion and one to two looping portions. The hat shaped portion includes an upper flat surface for attachment and downwardly extending sides. The looping portions includes a bottom flat surface for attachment and looping sides which loopingly extend backwardly toward the base of the hat shaped portion. The looping sides cooperate with the side of the hat portion to stabilize the beam during flexure thus increasing the strength to thickness ratio of the beam.

Abstract: Provided are cyclic hydrocarbons of Formula I ##STR1## with an aminoalkyl sidechain that are useful for treating phospholipase A2 mediated conditions, diabetes, and obesity.

Abstract: The present invention provides novel 3'-pyridinylalkenylindole-2-carboxylic acids and derivatives thereof of the formulas I and II ##STR1## which are useful as thromboxane A.sub.2 (TXA.sub.2) synthetase inhibitors and as such represent potent pharmacological agents.

Abstract: The present invention provides novel 3'-pyridinylalkenylindole-2-carboxylic acids and derivatives thereof of the formula I and II ##STR1## which are useful as thromboxane A.sub.2 (TXA.sub.2) synthetase inhibitors and as such represent potent pharmacological agents.